International Journal of STD & AIDS > Volume 19, Number 8 > Pp. 507-509

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Doshi, J S Articles by Allen, E Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original research articles

Acceptability of chlamydia screening using self-taken vaginal swabs

J S Doshi MFSRH MRCOG , J Power MFSRH MRCOG and E Allen MSc PhD

Department of Sexual and Reproductive Healthcare, Margaret Pyke Centre, 73 Charlotte Street, London W1T 4PL, UK

Correspondence to: Dr J S Doshi Email: jsdoshi{at}doctors.org.uk

In the first phase of the National Chlamydia Screening Programme (NCSP), the majority of sites involved offered testing with urine sample. Camden & Islington (C&I) were the first site to offer testing with self-taken vaginal swabs (SVS). SVS are appropriate specimens for diagnosing chlamydia by nucleic acid amplification tests. This study aimed to assess the uptake and acceptability of chlamydia screening using SVS within C&I contraceptive clinics. Data collected from women participating in the NCSP between June 2003 and April 2004 were analysed. Of the 3936 women who accepted screening, 90.4% provided a SVS and only 5.8% accepted the offer of providing a urine sample as an alternative to SVS. Women over 19 years and women from Asian ethnic groups were most likely to decline any screening. No woman stated a reluctance to provide a SVS as a reason for declining screening, confirming the acceptability of SVS for chlamydia screening.

Key Words: chlamydia • screening • women

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?